access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Grants Awarded

Thank you for your interest in our research. For your convenience we have listed grants awarded by principle investigator and by title.

Terry A. Day, M.D.

  • Rita M. Young, M.D., PI, Terry A. Day, M.D., Co-Investigator. Targeting mTOR as a Novel Mechanism-Based Therapy for Head and Neck Cancer. NIH/NCI, $99,999, 7/2009 to 6/2011.

Christopher M. Discolo, M.D.

  • Christopher M. Discolo, M.D., PI, David R. White, M.D., Co-Investigator. A Prospective, Multi-Center, Non-Randomized Clinical Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $23,500, 7/2010 to 6/2011.
  • Christopher M. Discolo, M.D., PI. Non-Randomized, Feasibility Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $15,000, 4/2010 to 3/2011.

Judy Dubno, Ph.D.

  • Judy R. Dubno, Ph.D., PI. Auditory Analysis and Speech Recognition. NIH/NIDCD, $137,625, 7/17/09 to 6/30/11.
  • Judy R. Dubno, Ph.D., PI. Auditory Analysis and Speech Recognition. NIH/NIDCD, $297,338, 7/1/06 to 6/30/11.
  • Judy R. Dubno, Ph.D., PI. Automated Hearing Tests. Audiology Inc. and NIH/NIDCD, $132,868, 4/1/10 to 3/13/13.
  • Judy R. Dubno, Ph.D., PI. Experimental and Clinical Studies of Presbyacusis. NIH/NIDCD, $348,432, 7/17/09 to 6/30/11.
  • Judy R. Dubno, Ph.D., PI. Experimental and Clinical Studies of Presbyacusis. NIH/NIDCD, $1,843,561, 8/1/08 to 7/31/13.
  • Judy R. Dubno, Ph.D., PI. Multi-site Study of the Efficacy of Speech Perception Training for Hearing-Aid Users. NIH/NIDCD, $300,640, 7/1/10 to 6/30/15.

Mark Eckert, Ph.D.

  • Mark Eckert, Ph.D., PI. Neural Changes Underlying Speech-Perception Training in the Aging Brain. Deafness Research Foundation, $50,000, 9/1/09 to 8/31/10.
  • Kelly C. Harris, M.D.
  • Kelly C. Harris, M.D., PI. Auditory Temporal Processing in the Aging Ear and Brain (Clinical Research). NIH/NIDCD, $52,719, 7/17/09 to 6/30/10.
  • Kelly C. Harris, M.D., PI. Auditory Temporal Processing in the Aging Ear and Brain (Research Training). NIH/NIDCD, $124,127, 9/1/07 to 8/31/12.

Joshua D. Hornig, M.D.

  • Joshua D. Hornig, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. A Prospective, Blinded, Randomized, Controlled Trial Comparing Wound Drainage and Post-Operative Complications with and without the Use of EVICEL Fibrin Sealant in Thyroidectomy. Ethicon, $100,000, 3/2010 to 2/2012.

Paul R. Lambert, M.D.

  • Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $131,300, 12/2009 to 12/2011.
  • Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $123,500, 8/2010 to 8/2012.
  • Paul R. Lambert, M.D., PI. A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 1B Study of Oto-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere's Disease. Otonomy Inc., $106,563, 12/2009 to 12/2010.

Ted A. Meyer, M.D., Ph.D.

  • Ted A. Meyer, M.D., Ph.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. The Effects of Apical Stimulation of the Cochlea Using Fine Structure Processing. Med El Coro, $43,500, 12/2009 to 12/2012.
  • Ted A. Meyer, M.D., Ph.D., PI,, Abby Connell, MEd, Co-Investigator. Electric-Acoustic Systems (EAS) Investigational Plan. MED-EL Corporation, $30,500, 8/2010 to 7/2012.
  • Ted A. Meyer, M.D., Ph.D., PI, Meredith Edgerton, AuD, Co-Investigator. Evaluation of the ClearVoice Strategy in Adults Using HiResolution Fidelity 120 Sound Processing. Advanced Bionics, $9,750, 12/2009 to 12/2011.
  • Ted A. Meyer, M.D., Ph.D., PI, Abby Connell, MEd, Co-Investigator. Market Assessment Evaluation. Cochlear Americas, $3,750, 7/2009 to 7/2011.
  • Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Ph.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $131,300, 12/2009 to 12/2011.
  • Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Ph.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $123,500, 8/2010 to 8/2012.

Shaun A. Nguyen, M.D., CPI

  • Shaun A. Nguyen, M.D., PI. Otology Data Collection Project CHEER. Academy of Otolaryngology – Head and Neck Surgery & Duke University, 1/2010 to 1/2011.
  • Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. The Effects of Apical Stimulation of the Cochlea Using Fine Structure Processing. Med El Coro, $43,500, 12/2009 to 12/2012.
  • Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Evaluation of the ClearVoice Strategy in Adults Using HiResolution Fidelity 120 Sound Processing. Advanced Bionics, $9,750, 12/2009 to 12/2011.
  • Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Market Assessment Evaluation. Cochlear Americas, $3,750, 07/2009 to 7/2011.
  • Rodney Schlosser, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Management of Allergic Rhinitis Patients with Nasal Steroids and Low Pressure Nasal Irrigation with Isotonic Saline: A Prospective Pilot Study. NellMed Pharmaceuticals Inc., $67,380, 12/2009 to 6/2011.
  • David R. White, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Natural History Study Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. Alcon Inc., $37,750, 7/2010 to 6/2011.
  • Joshua D. Hornig, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. A Prospective, Blinded, Randomized, Controlled Trial Comparing Wound Drainage and Post-Operative Complications with and without the Use of EVICEL Fibrin Sealant in Thyroidectomy. Ethicon, $100,000, 3/2010 to 2/2012.

Rodney Schlosser, M.D.

  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Andreoli S). Ciliary dysfunction in children with otitis media and tobacco exposure. MUSC University Research Committee, $2,000, 2010.
  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Andreoli S). Ciliary dysfunction in pediatric atopic disease. AAOA, $5,000, 2009 to 10.
  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Contribution of VD3 deficiency to immune dysfunction in children with chronic rhinosinusitis. American Society of Pediatric Otolaryngology, $20,000, 2010 to 2011.
  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Effects of fungal antigen exposure on epithelial cell induction of dendritic cell maturation in patients with AFRS. AAOA, $5,000, 2009 to 2010.
  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Effects of second hand smoke on dendritic cell regulation and function in chronic rhinosinusitis. Flight Attendants Medical Research Institute,Young Clinical Scientist Award, $225,000, 2010 to 2013.
  • Rodney Schlosser, M.D., PI. Determinants of Surgical/Medical Management Outcomes in Chronic Rhinosinusitis. American Rhinological Society & Oregon Health Sciences University, 6/2009 to 6/2012.
  • Rodney Schlosser, M.D., Mentor and co-investigator. (PI, O’ Connell B). Immunolocalization and regulation of Th2 cells in allergic fungal rhinosinusitis. AAOA, $5,000, 2009 to 10.
  • Rodney Schlosser, M.D., PI. Impact of Intraoperative Hydrodebrider Treatment on Post-op Sinonasal Inflammation. Medtronic Inc., $109,420, 7/2010 to 6/2011.
  • Rodney Schlosser, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Management of Allergic Rhinitis Patients with Nasal Steroids and Low Pressure Nasal Irrigation with Isotonic Saline: A Prospective Pilot Study. NellMed Pharmaceuticals Inc., $67,380, 12/2009 to 6/2011.
  • Rodney Schlosser, M.D., Co-investigator. (PI, Atkinson, C). Nanoparticle coupled therapeutics to inhibit smoke-induced oxidative inflammation in allergic rhinitis. SC Translational Research Institute, $50,000, 2009 to 2010.
  • Rodney Schlosser, M.D., PI. Second-hand smoke exacerbates allergic rhinitis. Flight Attendant Medical Research Institute, Clinical Innovator Award, $325,500, 2008 to 2011.

David R. White, M.D.

  • David R. White, M.D., PI, A prospective, randomized, double-blind placebo-controlled, multicenter, phase 1 study of OTO-201 given as a single intratympanic injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring tympanostomy tube Placement. Otonomy, Inc., $150,591. Sept 1, 2012 to present.
  • David R. White, M.D., PI. Surgical reduction of the inferior turbinate using a coblation device for treatment of nasal obstruction in a pediatric population. Arthrocare, $10,000. Feb 1, 2011 to August 1, 2012
  • Christopher M. Discolo, M.D., PI, David R. White, M.D., Co-Investigator. A Prospective, Multi-Center, Non-Randomized Clinical Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $23,500, 7/2010 to 6/2011.
  • David R. White, M.D., PI. Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. Alcon Inc., $76,750, 7/2010 to 6/2012.
  • David R. White, M.D., PI. Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. Alcon Laboratories, Inc., $35,250 Funding period: May 1, 2010 to March 31, 2012. (1 percent time)
  • David R. White, M.D., PI. Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. Alcon Laboratories, Inc., $73,750, May 1, 2010 to March 31, 2012.
  • David R. White, M.D., PI. Gastroesophageal reflux in otitis media. National Organization for Hearing Research, $10,000, July 2000 to June, 2001. 
  • David R. White, M.D. As Co-Investigator ;Standardization of video fluoroscopic swallow studies for bottle-fed children. NIH/NIDCD, $396,606, July 2011 to June 2014. PI: Bonnie Martin-Harris, PhD.
  • David R. White, M.D. As Co-Investigator A clinical study of the acclarent tympanostomy tube delivery system in-office. Acclarent, Inc., $3,125, August 2011 to October 2012. PI: Christopher M. Discolo, M.D.
  • David R. White, M.D. As Co-Investigator. Smoke exposure and oxidative inflammation in pediatric chronic rhinosinusitis. American Society of Pediatric Otolaryngology Core Grant., $10,000. July 1, 2010 to June 30, 2011. PI: Jennifer Mulligan, PhD.
  • David R. White, M.D. As Co-Investigator. Ciliary dysfunction in children with otitis media and tobacco exposure. University Research Committee Research Award, Medical University of South Carolina, $2,000, June 1 to October 31, 2010. PI: Steven Andreoli, M.D.
  • David R. White, M.D. As Co-Investigator. Ciliary dysfunction in pediatric atopic disease. American Academy of Otolaryngic Allergy Foundation, $5,000, July 2009 to June 2010. PI: Steven M. Andreoli, M.D.
  • David R. White, M.D. As Co-Investigator. A Prospective, Multi Center, Non-Randomized Clinical Trial To Evaluate The Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. Sponsored by Otosonics Medical, $25,000, July 2009 to July 2012. PI: Christopher M. Discolo, M.D.
  • David R. White, M.D. As Co-Investigator. Non-randomized feasibility trial to evaluate the ear effusion detection and characterization system (EEDCS) to detect middle ear fluid in children. Sponsored by Otosonics Medical, $15,000, July 2009 to present. PI:Christopher M. Discolo, M.D.

Rita M. Young, Ph.D.

  • Rita M. Young, Ph.D., PI. Defining and Interrupting the Pathways that Lead to HNSCC Invasiveness. VA Medical Center, $125,000, 10/1/07 to 9/30/11.
  • Rita M. Young, Ph.D., PI. Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity. VA Medical Center, $159,000, 10/1/09 to 9/30/14.
  • Rita M. Young, Ph.D., PI. Macrophage-Driven Progression of Premalignant Oral Lesions Toward Invasiveness. NIH/NIDCR, $315,000, 8/1/08 to 6/30/12.
  • Rita M. Young, Ph.D., PI. Immunotherapy to Prevent Oral Permalignant Lesion Recurrence and Oral Cancer. NIH/NCI, $261,450, 1/1/09 to 12/31/13.